SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Morgan Stanley – ‘10-Q’ for 3/31/18 – ‘EX-10.1’

On:  Friday, 5/4/18, at 4:43pm ET   ·   For:  3/31/18   ·   Accession #:  1193125-18-152899   ·   File #:  1-11758

Previous ‘10-Q’:  ‘10-Q’ on 11/3/17 for 9/30/17   ·   Next:  ‘10-Q’ on 8/3/18 for 6/30/18   ·   Latest:  ‘10-Q’ on 11/3/23 for 9/30/23   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/04/18  Morgan Stanley                    10-Q        3/31/18  131:34M                                    Donnelley … Solutions/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   2.15M 
 2: EX-10.1     Material Contract                                   HTML    116K 
 3: EX-12       Statement re: Computation of Ratios                 HTML     59K 
 4: EX-15       Letter re: Unaudited Interim Financial Info         HTML     47K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     43K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     43K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     38K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     38K 
15: R1          Document and Entity Information                     HTML     64K 
16: R2          Consolidated Income Statements (Unaudited)          HTML    149K 
17: R3          Consolidated Comprehensive Income Statements        HTML     67K 
                (Unaudited)                                                      
18: R4          Consolidated Balance Sheets                         HTML    137K 
19: R5          Consolidated Balance Sheets (Parenthetical)         HTML     68K 
20: R6          Consolidated Statements of Changes in Total Equity  HTML     74K 
                (Unaudited)                                                      
21: R7          Consolidated Cash Flow Statements (Unaudited)       HTML    163K 
22: R8          Introduction and Basis of Presentation              HTML     52K 
23: R9          Significant Accounting Policies                     HTML     66K 
24: R10         Fair Value Disclosures                              HTML   1.00M 
25: R11         Derivative Instruments and Hedging Activities       HTML    550K 
26: R12         Investment Securities                               HTML    465K 
27: R13         Collateralized Transactions                         HTML    253K 
28: R14         Loans and Allowance for Credit Losses               HTML    298K 
29: R15         Equity Method Investments                           HTML     53K 
30: R16         Deposits                                            HTML     59K 
31: R17         Borrowings and Other Secured Financings             HTML     68K 
32: R18         Commitments, Guarantees and Contingencies           HTML    218K 
33: R19         Variable Interest Entities and Securitization       HTML    349K 
                Activities                                                       
34: R20         Regulatory Requirements                             HTML    176K 
35: R21         Total Equity                                        HTML    218K 
36: R22         Earnings per Common Share                           HTML     82K 
37: R23         Interest Income and Interest Expense                HTML     68K 
38: R24         Employee Benefit Plans                              HTML     53K 
39: R25         Income Taxes                                        HTML     45K 
40: R26         Segment and Geographic Information                  HTML    180K 
41: R27         Customer Contract Revenue Recognition               HTML    108K 
42: R28         Subsequent Events                                   HTML     42K 
43: R29         Significant Accounting Policies (Policy)            HTML     62K 
44: R30         Fair Value Disclosures (Tables)                     HTML   1.02M 
45: R31         Derivative Instruments and Hedging Activities       HTML    554K 
                (Tables)                                                         
46: R32         Investment Securities (Tables)                      HTML    465K 
47: R33         Collateralized Transactions (Tables)                HTML    256K 
48: R34         Loans and Allowance for Credit Losses (Tables)      HTML    306K 
49: R35         Equity Method Investments (Tables)                  HTML     51K 
50: R36         Deposits (Tables)                                   HTML     59K 
51: R37         Borrowings and Other Secured Financings (Tables)    HTML     67K 
52: R38         Commitments, Guarantees and Contingencies (Tables)  HTML    181K 
53: R39         Variable Interest Entities and Securitization       HTML    348K 
                Activities (Tables)                                              
54: R40         Regulatory Requirements (Tables)                    HTML    165K 
55: R41         Total Equity (Tables)                               HTML    221K 
56: R42         Earnings per Common Share (Tables)                  HTML     81K 
57: R43         Interest Income and Interest Expense (Tables)       HTML     66K 
58: R44         Employee Benefit Plans (Tables)                     HTML     52K 
59: R45         Segment and Geographic Information (Tables)         HTML    185K 
60: R46         Customer Contract Revenue Recognition (Tables)      HTML    109K 
61: R47         Significant Accounting Policies (Details)           HTML     46K 
62: R48         Fair Value Disclosures (Assets and Liabilities      HTML    204K 
                Measured at Fair Value on a Recurring Basis)                     
                (Details)                                                        
63: R49         Fair Value Disclosures (Rollforward of Level 3      HTML    170K 
                Assets and Liabilities Measured at Fair Value on a               
                Recurring Basis) (Details)                                       
64: R50         Fair Value Disclosures (Valuation Techniques and    HTML    230K 
                Sensitivity of Unobservable Inputs Used in                       
                Recurring Level 3 Fair Value Measurements)                       
                (Details)                                                        
65: R51         Fair Value Disclosures (Measured Based on Net       HTML     61K 
                Asset Value) (Details)                                           
66: R52         Fair Value Disclosures (Earnings Impact of          HTML     46K 
                Instruments under the Fair Value Option) (Details)               
67: R53         Fair Value Disclosures (Gains (Losses) Due to       HTML     58K 
                Changes in Instrument-Specific Credit Risk)                      
                (Details)                                                        
68: R54         Fair Value Disclosures (Borrowings Measured at      HTML     54K 
                Fair Value) (Details)                                            
69: R55         Fair Value Disclosures (Excess of Contractual       HTML     44K 
                Principal Amount Over Fair Value) (Details)                      
70: R56         Fair Value Disclosures (Fair Value of Loans in      HTML     42K 
                Nonaccrual Status) (Details)                                     
71: R57         Fair Value Disclosures (Assets Measured at Fair     HTML     73K 
                Value on a Non-Recurring Basis) (Details)                        
72: R58         Fair Value Disclosures (Financial Instruments Not   HTML    126K 
                Measured at Fair Value) (Details)                                
73: R59         Derivative Instruments and Hedging Activities       HTML    185K 
                (Derivative Fair Values) (Details)                               
74: R60         Derivative Instruments and Hedging Activities       HTML    108K 
                (Derivative Notionals) (Details)                                 
75: R61         Derivative Instruments and Hedging Activities       HTML     81K 
                (Gains (Losses) on Accounting Hedges and Trading                 
                Revenues by Product Type) (Details)                              
76: R62         Derivative Instruments and Hedging Activities       HTML     52K 
                (Credit Risk-Related Contingencies) (Details)                    
77: R63         Derivative Instruments and Hedging Activities       HTML    120K 
                (Credit Derivatives and Other Credit Contracts)                  
                (Details)                                                        
78: R64         Investment Securities (AFS and HTM Securities)      HTML    134K 
                (Details)                                                        
79: R65         Investment Securities (Investment Securities in an  HTML    147K 
                Unrealized Loss Position) (Details)                              
80: R66         Investment Securities (Investment Securities by     HTML    202K 
                Contractual Maturity) (Details)                                  
81: R67         Collateralized Transactions (Offsetting of Certain  HTML    115K 
                Collateralized Transactions) (Details)                           
82: R68         Collateralized Transactions (Gross Secured          HTML     85K 
                Financing Balances) (Details)                                    
83: R69         Collateralized Transactions (Assets Pledged)        HTML     45K 
                (Details)                                                        
84: R70         Collateralized Transactions (Collateral Received)   HTML     43K 
                (Details)                                                        
85: R71         Collateralized Transactions (Customer Margin        HTML     39K 
                Lending and Other) (Details)                                     
86: R72         Collateralized Transactions (Restricted Cash and    HTML     46K 
                Segregated Securities) (Details)                                 
87: R73         Loans and Allowance for Credit Losses (Loans Held   HTML    126K 
                for Investment and Held for Sale) (Details)                      
88: R74         Loans and Allowance for Credit Losses (Impaired     HTML     66K 
                Loans) (Details)                                                 
89: R75         Loans and Allowance for Credit Losses (Tdr)         HTML     43K 
                (Details)                                                        
90: R76         Loans and Allowance for Credit Losses (Allowance    HTML     92K 
                for Loan Losses and Lending Commitments                          
                Rollforward) (Details)                                           
91: R77         Loans and Allowance for Credit Losses (Employee     HTML     49K 
                Loans) (Details)                                                 
92: R78         Equity Method Investments (Equity Method            HTML     45K 
                Investment Balances) (Details)                                   
93: R79         Equity Method Investments (Investees) (Details)     HTML     49K 
94: R80         Deposits (Details)                                  HTML     63K 
95: R81         Borrowings and Other Secured Financings (Long-Term  HTML     55K 
                Borrowings) (Details)                                            
96: R82         Borrowings and Other Secured Financings (Other      HTML     46K 
                Secured Financings) (Details)                                    
97: R83         Commitments, Guarantees and Contingencies           HTML     79K 
                (Commitments) (Details)                                          
98: R84         Commitments, Guarantees and Contingencies           HTML    111K 
                (Obligations under Guarantee Arrangements)                       
                (Details)                                                        
99: R85         Commitments, Guarantees and Contingencies           HTML    105K 
                (Contingencies) (Details)                                        
100: R86         Variable Interest Entities and Securitization       HTML     50K  
                Activities (Consolidated VIEs) (Details)                         
101: R87         Variable Interest Entities and Securitization       HTML     76K  
                Activities (Assets and Liabilities by Balance                    
                Sheet Caption) (Details)                                         
102: R88         Variable Interest Entities and Securitization       HTML    102K  
                Activities (Non-Consolidated VIEs) (Details)                     
103: R89         Variable Interest Entities and Securitization       HTML     85K  
                Activities (Transfers of Assets with Continuing                  
                Involvement 1) (Details)                                         
104: R90         Variable Interest Entities and Securitization       HTML     70K  
                Activities (Transfers of Assets with Continuing                  
                Involvement 2) (Details)                                         
105: R91         Variable Interest Entities and Securitization       HTML     50K  
                Activities (Proceeds from New Securitization                     
                Transactions and Sales of Loans) (Details)                       
106: R92         Variable Interest Entities and Securitization       HTML     53K  
                Activities (Assets Sold with Retained Exposure)                  
                (Details)                                                        
107: R93         Variable Interest Entities and Securitization       HTML     42K  
                Activities (Failed Sales) (Details)                              
108: R94         Regulatory Requirements (Narrative) (Details)       HTML     45K  
109: R95         Regulatory Requirements (Capital Measures)          HTML     82K  
                (Details)                                                        
110: R96         Regulatory Requirements (U.S. Bank Subsidiaries'    HTML     86K  
                Regulatory Capital and Capital Ratios) (Details)                 
111: R97         Regulatory Requirements (Broker-Dealer Regulatory   HTML     47K  
                Capital Requirements) (Details)                                  
112: R98         Total Equity (Dividends and Share Repurchases)      HTML     56K  
                (Details)                                                        
113: R99         Total Equity (Preferred Stock General Disclosure)   HTML     42K  
                (Details)                                                        
114: R100        Total Equity (Preferred Stock Outstanding)          HTML     83K  
                (Details)                                                        
115: R101        Total Equity (Aoci) (Details)                       HTML     59K  
116: R102        Total Equity (Components of Period Changes in OCI   HTML    175K  
                ) (Details)                                                      
117: R103        Total Equity (Cumulative Adjustments to Retained    HTML     51K  
                Earnings) (Details)                                              
118: R104        Earnings per Common Share (Calculation of Basic     HTML    101K  
                and Diluted EPS) (Details)                                       
119: R105        Interest Income and Interest Expense (Details)      HTML     66K  
120: R106        Employee Benefit Plans (Net Periodic Benefit        HTML     53K  
                Expense (Income)) (Details)                                      
121: R107        Segment and Geographic Information (Selected        HTML     97K  
                Financial Information by Business Segment)                       
                (Details)                                                        
122: R108        Segment and Geographic Information (Assets by       HTML     47K  
                Business Segment) (Details)                                      
123: R109        Segment and Geographic Information (Additional      HTML     43K  
                Information - Investment Management) (Details)                   
124: R110        Segment and Geographic Information (Net Revenues    HTML     46K  
                by Region) (Details)                                             
125: R111        Customer Contract Revenue Recognition (Customer     HTML     81K  
                Contract Renenues) (Details)                                     
126: R112        Customer Contract Revenue Recognition (Change in    HTML     63K  
                Revenue) (Details)                                               
127: R113        Customer Contract Revenue Recognition (Balance      HTML     51K  
                Sheet Amounts) (Details)                                         
128: R114        Customer Contract Revenue Recognition (Future       HTML     49K  
                Expected Revenues) (Details)                                     
130: XML         IDEA XML File -- Filing Summary                      XML    262K  
129: EXCEL       IDEA Workbook of Financial Reports                  XLSX    196K  
 9: EX-101.INS  XBRL Instance -- ms-20180331                         XML  13.13M 
11: EX-101.CAL  XBRL Calculations -- ms-20180331_cal                 XML    640K 
12: EX-101.DEF  XBRL Definitions -- ms-20180331_def                  XML   3.52M 
13: EX-101.LAB  XBRL Labels -- ms-20180331_lab                       XML   6.88M 
14: EX-101.PRE  XBRL Presentations -- ms-20180331_pre                XML   4.78M 
10: EX-101.SCH  XBRL Schema -- ms-20180331                           XSD    699K 
131: ZIP         XBRL Zipped Folder -- 0001193125-18-152899-xbrl      Zip    913K  


‘EX-10.1’   —   Material Contract


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



  EX-10.1  

Exhibit 10.1

AMENDED AND RESTATED TRUST AGREEMENT

by and between

MORGAN STANLEY

and

STATE STREET BANK AND TRUST COMPANY

As of January 1, 2018


AMENDED AND RESTATED TRUST AGREEMENT

Table of Contents

 

 

Section

   Page  

RECITALS

     1  

1.

  Trust Fund      2  

2.

  Payments to Trust Beneficiary      5  

3.

  Trustee Responsibility Regarding Payments to a Trust Beneficiary When the Company or any Subsidiary is Insolvent      7  

4.

  Term of the Trust and Payments to Company in Connection with Termination of the Trust      8  

5.

  Investment of Trust Assets      9  

6.

  Accounting by Trustee      10  

7.

  Responsibilities and Powers of Trustee      10  

8.

  Compensation and Expenses of Trustee      13  

9.

  Replacement of Trustee      14  

10.

  Amendment      14  

11.

  Severability and Alienation      15  

12.

  Governing Law      15  

13.

  Notices      15  

14.

  Signature in Counterparts      16  

  Exhibits:

 

  A.

1995 Equity Incentive Compensation Plan

 

  B.

Employees’ Equity Accumulation Plan

 

  C.

Directors’ Equity Capital Accumulation Plan

 

  D.

Equity Incentive Compensation Plan

 

  E.

2009 Replacement Equity Incentive Compensation Plan for MSSB Employees

 

   ii   


AMENDED AND RESTATED

TRUST AGREEMENT

This AMENDED AND RESTATED TRUST AGREEMENT (this “Agreement”), made as of the 1st day of January, 2018, by and between MORGAN STANLEY, a Delaware corporation (the “Company”), and STATE STREET BANK AND TRUST COMPANY, a Massachusetts trust company (in its individual capacity, “State Street” and, as trustee under this Agreement, the “Trustee”), hereby amends and restates the Amended and Restated Trust Agreement dated as of October 18, 2011 between the Company and State Street.

RECITALS:

WHEREAS, certain Managing Directors, Executive Directors, officers, other key employees and consultants of the Company or certain subsidiaries thereof (“Participants”) are eligible to receive shares (the “Benefits”) of the Company’s common stock, par value $0.01 per share (the “Stock”), pursuant to awards of stock units under any of the following plans of the Company:

    the 1995 Equity Incentive Compensation Plan;
    the Employees’ Equity Accumulation Plan;
    the Directors’ Equity Capital Accumulation Plan (“DECAP”);
    the Equity Incentive Compensation Plan
    the 2009 Replacement Equity Incentive Compensation Plan for Morgan Stanley Smith Barney Employees; and
    each other plan which the Company identifies to the Trustee in accordance with Section 11 of this Agreement,

as each may be amended, supplemented, replaced or extended, or any successor plan providing for similar benefits or awards, being hereinafter referred to collectively as the “Plans”. Copies of the first five of the Plans cited above are attached hereto as Exhibits A, B, C, D and E, respectively, and made a part hereof; and

WHEREAS, the Company wishes to establish a trust (a “Trust”), for the purpose of holding all of the shares of Stock underlying or associated with stock unit awards under the Plans, and to transfer to the Trust shares of Stock to be held therein, subject to the Company’s power to revoke the Trust in accordance with the terms thereof, in whole or in part, at any time or from time to time, until distributed to the


Participants and their beneficiaries (“Trust Beneficiaries”) as Benefits in such manner and at such time as specified in the Plans;

NOW, THEREFORE, for good and valuable consideration, the parties do hereby agree to amend and restate this Agreement and agree that the Trust shall be composed, held and disposed of as follows:

Section 1. Trust Fund.

(a) The Company has deposited with the Trustee in trust one share of Stock and cash in the amount of one thousand dollars ($1,000.00) which was the initial principal of the Trust to be held, administered and disposed of by the Trustee as provided in this Agreement together with additional deposits by the Company of cash or Stock from time to time. Subject to the terms of this Agreement, the initial deposit, any additional deposits, and any other assets held in the Trust shall be subject to the claims of the creditors of the Company and of any Company subsidiary that employs a Participant who is a Trust Beneficiary under this Agreement (each a “Subsidiary”) but, in the case of creditors of any Subsidiary, only to the extent of the assets held by the Trust in respect of employees (including former employees) of such Subsidiary and such additional assets, if any, as may be required to qualify the Trust as a grantor trust, within the meaning of Sections 671-677 of the Internal Revenue Code of 1986, as amended (the “Code”) (with respect to each Subsidiary, the “Allocable Assets”).

The Trust shall be funded only with shares of Stock, cash to purchase such shares, and, as applicable in accordance with Section 1(f) hereof, cash with respect to dividends paid on such shares of Stock. In addition, the Trustee may retain cash or short term instruments for payment of expenses and liabilities of the Trust. Shares of Stock contributed to the Trust or purchased with cash so contributed shall either be allocated to stock units (including dividend equivalents with respect to such stock units to be paid in Shares) awarded under the Plans (“Allocated Shares”) or be held in the Trust pending allocation to such stock units or other equity-based awards (“Unallocated Shares”). For purposes hereof, Unallocated Shares include shares of Stock held in the Trust that were considered Allocated Shares when contributed to, or purchased with cash held by, the Trust, but for which the corresponding stock units awarded under the Plans have been forfeited. The Company shall from time to time identify to the Trustee (i) all Allocated Shares that correspond to stock units awarded under DECAP, with such shares referred to herein as the “DECAP Portfolio,” (ii) all Allocated Shares that correspond to stock unit awards that provide for dividend

 

   2   


equivalents on such stock units to be reinvested in shares of Stock (other than Allocated Shares attributed to the DECAP Portfolio), with such shares (together with shares purchased pursuant to such dividend reinvestment) referred to herein as the “Dividend Reinvestment Shares,” and (iii) all Allocated Shares that correspond to stock unit awards granted to Trust Beneficiaries that, pursuant to the terms of the award as set forth in the applicable award documentation, do not provide for dividend equivalents on such stock units (such shares referred to herein as the “Non-Dividend Shares”). Further, the Company shall from time to time identify to the Trustee Allocated Shares that correspond to stock units awarded under the Plans and which shall be deemed to constitute, and shall be referred to, as the “Non-Passthrough Portfolio.” The Company shall also from time to time identify to the Trustee those Trust Beneficiaries who have been awarded stock units for which corresponding shares of Stock are held in the Non-Passthrough Portfolio. Such Trust Beneficiaries are referred to as “Non-Passthrough Participants.”

(b) Except as otherwise provided herein, the Trust hereby established shall be revocable by the Company, in whole or in part, at any time or from time to time, without the consent of any other person or entity. Subject to the provisions of Section 3 and notwithstanding any other provision in this agreement to the contrary, (i) the Company may not revoke the Trust to the extent of any shares corresponding to a stock unit award of a Trust Beneficiary which award at the time of such revocation is unsettled but currently payable, all in accordance with the terms of the Plans and the award granted thereunder and (ii) the Company may not revoke the Trust to the extent of any dividend payable to the Trustee as record owner on the record date which dividend at the time of such revocation is unsettled but currently distributable by the Trustee as a dividend equivalent to any Trust Beneficiary, in accordance with paragraph (f) of this Section 1 and the terms of the Plan and the award granted thereunder. It is specifically noted that the Company may terminate the Trust to the extent of any Unallocated Shares at any time.

(c) The Trust is intended to be a grantor trust, within the meaning of Sections 671-677 of the Code, and shall be construed accordingly.

(d) The assets of the Trust shall be held separate and apart from other funds of the Company and shall be used exclusively for the uses and purposes herein set forth. Notwithstanding any other provision of this Agreement to the contrary and subject to the provisions of Section 3, no Trust Beneficiary shall have any claim on, or any beneficial ownership interest in, any assets of the Trust other than assets to which the

 

   3   


Trust Beneficiary is entitled to a distribution as provided in Section 2 and paragraph (f) of this Section 1. No rights to a distribution of a Benefit or dividends declared thereon shall be created under this Agreement independently of any Trust Beneficiary’s right to a distribution or payment under the Plans and the awards granted thereunder. Neither the Company nor the Trustee shall have any power to create a security interest in the assets of the Trust in favor of any Trust Beneficiary, any person entitled to Benefits by reason of the death of any Trust Beneficiary or any creditor of either the Company or any Subsidiary. Nothing contained herein or in any provision of the Plans shall operate to create a security interest in any part of the assets of the Trust on behalf of any Trust Beneficiary or any person entitled to Benefits upon the death of any Trust Beneficiary.

(e) The Company may at any time or from time to time make additional deposits of cash or shares of Stock to the Trust to augment the assets to be held, administered and disposed of by the Trustee as provided in this Agreement. The Trustee shall have no duty or obligation to require the Company to make any contribution to the Trust.

(f) Any cash dividend paid in respect of Allocated Shares held in the Trust shall be distributed by or on behalf of the Trustee as a dividend equivalent to Trust Beneficiaries as and when directed by the Company, except to the extent any Trust Beneficiaries are not entitled to dividends or dividend equivalents pursuant to the terms of the applicable award with respect to which the Allocated Shares relate. If a Participant (Trust Beneficiary) is not eligible or entitled to receive dividends or dividend equivalents with respect to stock unit awards pursuant to the terms of the applicable award, then, as directed by the Company, the Trustee shall (x) waive the right to receive dividends with respect to any Allocated Shares underlying such awards, (y) deliver the aggregate amount of dividends paid to the Trust with respect to any such shares to the Company, or (z) retain the cash dividends paid in respect to such shares to be used for payment of expenses and liabilities of the Trust. Any cash dividend paid in respect of Dividend Reinvestment Shares shall, as promptly as possible after receipt thereof by the Trustee, be paid by the Trustee to the Company in consideration for the purchase of a number of additional shares of Stock determined by dividing (1) the aggregate amount of the cash dividend paid on all shares of Stock that are Dividend Reinvestment Shares on the dividend record date by (ii) the fair market value (as determined by the Company in its sole discretion) of one share of Stock on the dividend payment date. The Company shall

 

   4   


be responsible for calculating the number of shares to be purchased by the Trustee. All shares of Stock purchased by the Trustee pursuant to the third sentence of this paragraph (f) will be treated as Dividend Reinvestment Shares and will be treated as dividend equivalents allocated to Participants in accordance with the applicable Plan. Any cash dividend paid in respect of Unallocated Shares held in the Trust shall be delivered by the Trustee to the Company. The Company shall act as agent for the Trustee in making distributions of dividend equivalents to Trust Beneficiaries unless the Trustee gives the Company 90 days’ notice, in writing, that the Trustee does not want the Company to act as its agent. The Trustee may require the Company to provide certification of its distributions of dividend equivalents to Trust Beneficiaries. Any other dividend or distribution made with respect to the shares of Stock held in the Trust shall be distributed to the Trustee and delivered by the Trustee to the Company for disposition by the Company (i) in the case of Allocated Shares, in accordance with the Plan and awards granted thereunder, and (ii) in the case of Unallocated Shares, as determined by the Company in its discretion.

(g) Any cash dividend paid in respect of shares of Stock included in the DECAP Portfolio shall, as promptly as possible after receipt thereof by the Trustee, be paid by the Trustee to the Company in consideration for the purchase of a number of additional shares of Stock determined by dividing (i) the aggregate amount of the cash dividend paid on all shares of Stock included in the DECAP Portfolio on the dividend record date by (ii) the Fair Market Value, as defined in DECAP, of one share of Stock on the dividend payment date. The Company shall be responsible for calculating Fair Market Value in accordance with the preceding sentence and the number of shares to be purchased by the Trustee. All shares of Stock purchased by the Trustee pursuant to this paragraph (g) will be included in the DECAP Portfolio and will be treated as dividend equivalents allocated to participants in DECAP in accordance with the Plan.

Section 2. Payments to Trust Beneficiary.

(a) The Trustee shall distribute the Benefits and, if provided for in the terms of the Plans and awards granted thereunder, any dividend equivalents accumulated thereon, in accordance with the Plans as and when directed by the Compensation, Management Development and Succession Committee (the “Committee”) of the Board of Directors of the Company or by an officer of the Company, as hereinafter set forth, if and to the extent that neither the Company nor any of its Subsidiaries is insolvent at the time of such distribution and shares of Stock are available for such distribution. Subject to the provisions of

 

   5   


Section 3, a Trust Beneficiary shall be entitled to a distribution of Benefits from the Trust at the time the stock unit award becomes currently payable and is no longer subject to forfeiture, all in accordance with the terms of the Plans and the award granted thereunder, provided that the Trust has not been revoked prior to such time and that the Company’s obligation under the stock unit award has not been satisfied otherwise. The Committee or an officer of the Company will instruct the Trustee as to the eligibility of any Trust Beneficiary for such distribution, the correct amount of each distribution and when to make the distribution. The Committee or its designee shall keep accurate records with respect to the Benefits and, if provided for in the terms of the Plans and awards granted thereunder, any dividend equivalents accumulated thereon, payable from the Trust and the Trustee may rely upon such records without a duty of further inquiry in performing its duties under this Agreement. To the extent Benefits and, if provided for in the terms of the Plans and awards granted thereunder, any dividend equivalents accumulated thereon, have been paid from the Trust hereunder, the Company shall be relieved of its obligation to pay such Benefits.

(b) If at any time the number of shares held in the Trust is not sufficient to make any directed distribution of Benefits, in accordance with the Plans, to any Trust Beneficiary then entitled to a distribution, the Trustee shall distribute the balance of the shares held in the Trust to or on behalf of all the Trust Beneficiaries then entitled to distributions in the following manner: the Benefits distributed to any Trust Beneficiary shall be equal to the balance of shares held in the Trust multiplied by a fraction the numerator of which is the amount of Benefits such Trust Beneficiary is entitled to distribution of at that time and the denominator of which is the amount of Benefits all Trust Beneficiaries are entitled to distribution of at that time. No provision of this Trust Agreement shall relieve the Company of its liabilities to pay Benefits except to the extent that the same have been paid from the Trust hereunder.

(c) The Trustee shall make provision for withholding of any federal, state or local taxes that may be required to be withheld in respect of any distribution from the Trust as directed by the Committee or by an officer of the Company and the Trustee shall remit any shares or other amounts so withheld as instructed by the Committee or by an officer of the Company, including to the Company if so instructed by the Committee or by such officer.

 

   6   


  Section 3.   Trustee Responsibility Regarding Payments to a Trust Beneficiary When the Company or any Subsidiary Is Insolvent.

(a) The Company or a Subsidiary of the Company shall be considered “Insolvent” for purposes of this Trust Agreement if (i) the Company or the Subsidiary, whichever is applicable, is unable or otherwise fails to pay its debts, other than debts owed to the Company or to entities 50% or more owned or controlled, directly or indirectly, by the Company, as they mature in accordance with the terms of the relevant debt instruments or (ii) the Company or the Subsidiary is subject to a pending proceeding as a debtor under Title 11 of the United States Code (11 U.S.C. § 101 et seq.), as amended from time to time, or any successor statute or under Title 15 of the United States Code (15 U.S.C. § 78aaa et seq.), as amended from time to time, or any successor statute. If the Company is Insolvent, the Trustee promptly shall discontinue distributing Benefits under Section 2 and dividends, dividend equivalents or other income earned on the shares of Stock or other assets held in Trust, and if a Subsidiary is Insolvent, the Trustee promptly shall discontinue distributing Benefits under Section 2 and dividends, dividend equivalents or other income earned on the shares of Stock or other assets held in the Trust that constitute such Subsidiary’s Allocable Assets to any Trust Beneficiaries who are employees (including former employees) of such Subsidiary. Thereafter, subject to paragraph (b) below, the Trustee shall hold all of the assets and income of this Trust (or, in the case of a Subsidiary that is Insolvent, shall hold all of such Subsidiary’s Allocable Assets and any dividends or other income earned thereon) for the benefit of the general creditors of the Company or such Subsidiary, as the case may be, or both, and shall make such assets and income available to such general creditors at such times and in such amounts as directed by a court of competent jurisdiction. The Company shall not replace any shares of Stock paid to such general creditors. Notwithstanding the foregoing, if new awards of stock units are made, shares of Stock corresponding to such stock units may be contributed to the Trust.

(b) The Board of Directors or the Chairman or President of the Company shall have the duty to inform the Trustee promptly if the Company or any of its Subsidiaries becomes Insolvent. If a person claiming to be a creditor of the Company or any of its Subsidiaries alleges in writing to the Trustee that the Company or a Subsidiary has become Insolvent, the Trustee, to the extent set forth in Section 3(a), promptly shall suspend the distribution of Benefits under Section 2 and of dividend equivalents or other income earned on the shares of Stock or other assets held in Trust and shall contact the Company’s Chairman or

 

   7   


President and the Board of Directors. If the Company’s Chairman or President or the Board of Directors fails to confirm or deny such claim, the Trustee shall continue the suspension of Benefit distributions to Trust Beneficiaries and of income on the assets held in Trust until or unless a court of competent jurisdiction shall have determined that neither the Company nor any of its Subsidiaries is Insolvent. The Trustee shall also have the right at any time to apply to a court of competent jurisdiction for instructions on how to proceed if the Trustee determines that such action is necessary or appropriate in light of any uncertainty that may reasonably exist regarding whether or not the Company or a Subsidiary is Insolvent. Unless the Trustee has actual knowledge that the Company or a Subsidiary is Insolvent, the Trustee shall have no duty to inquire whether the Company or any of its Subsidiaries is Insolvent. In the absence of actual knowledge to the contrary, if the Trustee is notified pursuant to the foregoing provisions by a court of competent jurisdiction, by the Company’s Chairman or President or by the Board of Directors that the Company or, in the case of a Subsidiary, such Subsidiary is not or is no longer Insolvent, the Trustee shall resume the distribution of Benefits under Section 2 and of dividend equivalents or other income earned on the shares of Stock or other assets held in the Trust. Upon resumption of the distribution of Benefits by the Trustee, the first distribution to each Trust Beneficiary to whom distributions were so suspended shall include (to the extent that shares are available therefor) the amount by which the aggregate of all distributions which would have been made to such Trust Beneficiary in accordance with instructions given by the Committee or by officers of the Company, but for the discontinuance of distributions pursuant to paragraph (a) above, exceeds the aggregate distributions on account of Benefits actually made to such Trust Beneficiary by the Company (as certified to the Trustee by the Company in writing) during such period of discontinuance.

 

  Section 4.   Term of the Trust and Payments to Company in Connection with Termination of the Trust.

Unless sooner terminated, this Trust shall terminate upon the earlier of (a) the satisfaction of all the Company’s obligations under the Plans to the Trust Beneficiaries, (b) the receipt of an offer (including but not limited to a tender offer or exchange offer within the meaning of the Securities Exchange Act of 1934 as from time to time amended and in effect) to acquire any shares of Stock held by the Trustee in the Trust, other than an offer by the Company or any affiliate 50% or more of which was owned or controlled

 

   8   


directly or indirectly by the Company prior to the transaction (a “Self-Tender”), or (c) the twenty-first anniversary of the death of the last to survive of the employees of the Company or its subsidiaries who are Trust Beneficiaries as of the date of execution of this Agreement. Upon any termination of the Trust, all shares of Stock and other assets, if any, held in the Trust shall be delivered to the Company or as otherwise directed by the Company. The Company shall direct the Trustee as to the distribution of such shares and other assets no later than the final payment date for any stock units to which there correspond Allocated Shares held in the Trust.

Section 5. Investment of Trust Assets.

Unless otherwise directed by the Committee or by an officer of the Company and subject to the Trustee’s discretion to retain cash or short term instruments for the payment of expenses and liabilities of the Trust, other than with respect to cash dividends paid in respect of Allocated Shares held in the Trust and interest earned thereon (as described below), cash contributed by the Company shall be invested in shares of Stock. Except as otherwise provided herein, assets of the Trust shall be invested in shares of Stock at all times.

Notwithstanding anything in this Agreement to the contrary, any cash dividends paid in respect of Allocated Shares other than Non-Dividend Shares that, pursuant to the Plans and any applicable award, (A) are not either (i) used to purchase shares of Stock in connection with stock unit awards that provide for dividend equivalents on such stock units to be reinvested in shares of Stock or (ii) immediately distributable as dividend equivalents, but (B) are instead to be credited with respect to a Participant’s vested and unvested stock units and distributed as dividend equivalents at a future time when the stock unit award(s) corresponding to such Allocated Shares become currently payable, shall be invested in short-term investments, as directed by the Committee or by an officer of the Company, until the Trustee is otherwise directed by the Committee or by an officer of the Company or until the Trust Beneficiaries, who are entitled to the cash dividend equivalents pursuant to the terms of the Plans and awards granted thereunder, shall be entitled to receive distributions from the Trust (or the Company, as agent for the Trustee, as described in Section 1(f)) in accordance with the Plans and awards granted thereunder.

 

   9   


Section 6. Accounting by Trustee.

The Trustee shall keep accurate and detailed records of all investments, receipts, disbursements, and all other transactions, including such specific records as shall be agreed upon in writing between the Company or the Committee and the Trustee. All such accounts, books and records shall be open to inspection and audit at all reasonable times by the Company, its officers and the Committee. Within sixty (60) days following the close of each calendar year, the removal or resignation of the Trustee or the termination of this Trust, the Trustee shall deliver to the Company a written account of its administration of the Trust during such year or during the period from the close of the last preceding year to the date of such removal, resignation or termination, setting forth all investments, receipts, disbursements and other transactions effected by it, and showing all cash, securities and other property held in the Trust at the end of such year or as of the date of such removal, resignation or termination, as the case may be. Upon written request a Trust Beneficiary may examine the Trustee’s records and accounts regarding the number of shares of Stock held in the Trust and the dividends paid on such shares during the current year; provided that no Trust Beneficiary shall have any right to see such records or accounts as they relate to individual interests in the Trust other than his own.

Section 7. Responsibilities and Powers of Trustee.

(a) The Trustee shall act with the care, skill, prudence and diligence under the circumstances then prevailing that a prudent man acting in a like capacity and familiar with such matters would use in the conduct of an enterprise of a like character and with like aims; provided, however, that the Trustee shall incur no liability to anyone for (i) any action taken pursuant to a direction, request, or approval given by the Company, by the Committee or by an officer of the Company contemplated by and complying with the terms of this Trust Agreement or (ii) any inaction taken because of the failure of the Company, the Committee or an officer of the Company to give such a direction, request or approval, except in the case of the gross negligence or willful misconduct or from the Trustee’s breach of this Agreement. To the extent that the Trustee is acting pursuant to such direction, request or approval or is not acting because of the absence thereof and has not acted with gross negligence or willful misconduct, the Trustee shall be relieved of the “prudent man rule” for investments.

 

   10   


(b) Subject to the provisions of Section 3(b), the Trustee shall have no duty to make an independent investigation as to the occurrence of any event giving rise to a distribution hereunder or under the Plans, and shall be entitled to rely conclusively on the determinations of the Company, the Board of Directors, the Company’s Chairman or President, the Committee or an officer of the Company, as the case may be, as to the occurrence of any such event, which determinations shall be binding upon the Trustee, the Company and the Trust Beneficiaries. The Company shall indemnify the Trustee against losses, liabilities, claims, costs and expenses in connection with the administration of the Trust (including in connection with litigation undertaken or defended by the Trustee and in connection with action taken or omitted in accordance with this Agreement, unless resulting from the gross negligence or willful misconduct of the Trustee). This indemnification shall also extend to the officers, employees and agents of the Trustee. To the extent, but only to such extent, that the Company fails to make any payment on account of an indemnity provided in this Section 7, such payment shall be made from the Trust assets; provided, however, that the amount of any such payment from the Trust shall thereafter constitute a claim of the Trustee on behalf of the Trust against the Company and may be offset by the Trustee against any amount payable to the Company pursuant to Section 2(c).

(c) The Trustee may hire agents, accountants and attorneys (including the Company’s attorneys) to assist with its responsibilities under this Agreement subject to the consent of the Company.

(d) The Trustee shall have, without exclusion, all powers conferred on trustees by applicable law unless expressly provided otherwise herein.

(e) The Committee and the officers of the Company shall direct the Trustee in administering the Trust, as provided in this Agreement.

(f) Any corporation into which the Trustee (or any other corporation acting as Trustee) shall be merged or with which it shall be consolidated, or any corporation resulting from any merger, reorganization or consolidation to which it shall be a party, or any corporation to which all or substantially all of its trust business shall be transferred, shall be the successor of the Trustee (or of any other corporation acting as Trustee) as Trustee under this Agreement, without the execution or filing of any instrument or the performance of any further act or the order or judgment of any court and with the same powers, authorities and discretions.

 

   11   


(g) Until such time as the Company amends the Trust to provide otherwise, the Trustee shall have no discretion or authority to vote Stock held in the Trust by the Trustee on any matter presented for a vote of the stockholders of the Company except in accordance with the provisions of this paragraph (g). The Trustee shall solicit instructions from each Trust Beneficiary (x) who is an active employee (an “Active Employee”) of the Company or any of its subsidiaries or affiliates or (y) who has been awarded stock units for which corresponding shares of Stock are held in the DECAP Portfolio (a “DECAP Participant”), as indicated by the Company, as to the manner in which the shares of Stock held in the Trust corresponding to stock units awarded to such Trust Beneficiary under the Plans (including any shares of Stock comprising dividend equivalents corresponding to such stock units) shall be voted, provided, however, that the Trustee shall not solicit such instructions from Non-Passthrough Participants. The Trustee shall follow all proper instructions that are timely received with respect to such shares of Stock. Without limiting the generality of the preceding sentence, unless instructions provide to the contrary they shall be deemed to include authorization for the Trustee to vote, after due consideration, in its discretion (which discretion includes the discretion to grant a proxy to Company management to vote) any shares of Stock held in the Trust on such matters, other than matters identified in the relevant notice of meeting of the Company’s stockholders and for which the Trust Beneficiary has specified voting instructions, as may properly come before the meeting (“Other Matters”). The Trustee shall vote all Stock held in the Trust as to which no proper instructions are received (including Stock as to which instructions are not solicited and Stock as to which instructions are solicited but not received) (“Uninstructed Shares”) in proportion to Stock for which proper instructions have been received from Active Employees; provided, however, that the Trustee may vote, after due consideration, in its discretion, which discretion includes the discretion to grant a proxy to Company management to vote, any Uninstructed Shares on any Other Matter; and provided, further, that the Trustee shall not vote or grant a proxy to vote any Uninstructed Shares held in the DECAP Portfolio.

The Trustee shall communicate or cause to be communicated to each Trust Beneficiary the provisions of this Agreement relating to the right of such Trust Beneficiary, while an Active Employee (other than a Non-Passthrough Participant) or a DECAP Participant, to direct the Trustee with respect to the voting of shares of Stock corresponding to such Trust Beneficiary’s stock units (including any shares of Stock comprising dividend equivalents corresponding to such stock units). Such communication shall also

 

   12   


discuss the consequences of an instruction to abstain or withhold authority to vote and any failure to timely instruct the Trustee.

(h) The Company shall promptly notify each Trust Beneficiary of the existence of the Trust and such Beneficiary may examine a copy of this Agreement upon request. The Trustee shall distribute or cause to be distributed any and all communications required by paragraph (g) of this Section 7. The Company shall provide the Trustee with such information and assistance as the Trustee may reasonably request in connection with any communications or distributions to Trust Beneficiaries.

(i) Notwithstanding anything in this Agreement to the contrary, any cash, or income on other proceeds, received as a result of a transaction presented to a vote of Stockholders or as a result of a Self-Tender shall be invested in short-term instruments as directed by the Committee or by an officer of the Company, until the Trustee is otherwise directed by the Committee or by an officer of the Company or until the Trust Beneficiaries, to whose stock unit awards the shares subject to such transaction corresponded, shall be entitled to receive distributions from the Trust in accordance with the Plans.

Section 8. Compensation and Expenses of Trustee.

(a) The Trustee shall be entitled to receive such reasonable compensation for its services and reimbursement for reasonable expenses incurred with respect to the administration of the Trust, including fees incurred by the Trustee pursuant to Section 7(c) of this Agreement, in either case as shall be agreed upon between the Trustee and the Company. Such compensation and expenses shall be paid (1) first, from the amount of interest earned by the Trust with respect cash dividends paid in respect of shares of Stock held by the Trust for the payment of corresponding dividend equivalents to the Trust Beneficiaries in accordance with the terms of the Plans and awards granted thereunder, and (2) to the extent such interest is insufficient or otherwise unavailable to pay in full such compensation and expenses, by the Company; provided, however, that if such compensation and expenses are not paid by the Company after demand from the Trustee, then such compensation and expenses otherwise payable by the Company pursuant to clause (2) above may be paid from the assets of the Trust and the amount of any such payment from the Trust shall thereafter constitute a claim of the Trustee on behalf of the Trust against the Company and may be offset by the Trustee against any amount payable to the Company pursuant to Section 2(c).

 

  

13

  


Section 9. Replacement of Trustee.

(a) The Trustee may resign at any time, subject to the appointment and qualification of a successor trustee, by giving 60 days prior notice of such resignation in writing to the Company. The Trustee may be removed by the Company at any time without prior notice. In the event of the resignation or removal of the Trustee, a successor corporate trustee shall be appointed by the Company.

(b) In the event of the appointment of a successor trustee, such successor trustee will succeed to all the right, title and estate of, and will be, the Trustee; and the retiring trustee will after the settlement of its final account and the receipt of any compensation or expenses due it, deliver the Trust to the successor trustee together with all such instruments of transfer, conveyance, assignment and further assurance as the successor trustee may reasonably require.

Section 10. Amendment.

(a) This Agreement may be amended by a written instrument executed by the Company at any time and to any extent except that, subject to the limitation below, in no event shall the rights of the creditors of the Company or any Subsidiary be diminished and no amendment may be made which would permit the Company to revoke the Trust to the extent of (i) any shares corresponding to a stock unit award of a Trust Beneficiary which award is unsettled but currently payable or (ii) any dividend payable to the Trustee as record owner on the record date which dividend is distributable by the Trustee as a dividend equivalent to any Trust Beneficiary in accordance with Section 1(f) hereof. In addition, no amendment may be made without the Trustee’s consent which would change the Trustee’s duties or responsibilities under this Agreement.

(b) The Plans may be amended from time to time by the Company in accordance with their terms without the consent or concurrence of the Trustee and the Company will provide the Trustee with such amendments in a timely manner. The Company shall provide the Trustee with a copy of any amendment, certified by the Company’s Secretary, Assistant Secretary or such person’s designee, within 90 days after its adoption. In the event of any conflict between the Plans and this Agreement concerning the Trustee’s responsibilities, this Agreement shall govern.

 

   14   


Section 11. Severability and Alienation.

(a) Any provision of this Agreement prohibited by law shall be ineffective to the extent of any such prohibition without invalidating the remaining provisions hereof and this Agreement shall be reconstituted and enforceable as if such illegal provision were never included.

(b) Subject to the provisions of Section 3, Benefits under this Agreement may not be anticipated, assigned (either at law or in equity), alienated or subject to attachment, garnishment, levy, execution or other legal or equitable process.

In addition to the foregoing, the Company from time to time may unilaterally amend the definition of “Plans” set forth in the first Whereas clause of this Agreement to include additional plans of the Company or one of its subsidiaries which provide for awards of stock units. The Company shall effect any such amendment by providing the Trustee with written notice identifying the plan or plans to be added to the definition of “Plans” and shall furnish the Trustee with a copy of the relevant plan or plans. Following such actions by the Company, the plan or plans so identified shall be included among the plans which collectively constitute the “Plans” for purposes of this Agreement, and such plan or plans shall be considered a part hereof.

Section 12. Governing Law.

This Agreement shall be governed by and construed in accordance with the laws of the Commonwealth of Massachusetts.

Section 13. Notices.

(a) Communications to the Company or Committee shall be addressed to the Company or Committee, as applicable, at 1585 Broadway, New York, New York 10036, Attn: Chief Legal Officer and Secretary, provided, however, that upon the Company’s or Committee’s written request, such communications shall be sent to such other address as the Company or Committee may specify.

(b) Communications to the Trustee shall be addressed to CitiStreet at Company Stock Management, 200 Newport Avenue, JQ3N, North Quincy, Massachusetts 02171, Attn: Anne Muir; provided, however, that upon the Trustee’s written request, such communications shall be sent to such other address as the Trustee may specify.

(c) No communication shall be binding on the addressee thereof prior to receipt thereof.

 

   15   


Section 14. Signature in Counterparts.

This Agreement may be signed in counterparts, each of which shall be an original but all of which together will constitute one and the same instrument.

 

   16   


IN WITNESS WHEREOF, the Company and State Street have executed this Agreement as of the date first above written.

 

MORGAN STANLEY

By:  

 

/s/ Martin M. Cohen

 

Name: Martin M. Cohen

 

Title:   Secretary

 

STATE STREET GLOBAL ADVISORS TRUST COMPANY

By:  

 

/s/ Monet Ewing

 

Name: Monet Ewing

 

Title: Vice President

 

   17   


The following exhibits are already filed as exhibits to registration statements filed by Morgan Stanley or its predecessor companies under the Securities Act or to reports or registration statements filed by Morgan Stanley or its predecessor companies under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), respectively, and are hereby incorporated by reference to such statements or reports. Morgan Stanley’s Exchange Act file number is 1-11758. The Exchange Act file number of Morgan Stanley Group Inc., a predecessor company (“MSG”), was 1-9085.

Exhibit A: 1995 Equity Incentive Compensation Plan, as amended

(Annex A to MSG’s Proxy Statement for its 1996 Annual Meeting of Stockholders) as amended by Amendment (Exhibit 10.39 to Morgan Stanley’s Annual Report on Form 10-K for the fiscal year ended November 30, 2000), Amendment (Exhibit 10.5 to Morgan Stanley’s Quarterly Report on Form 10-Q for the quarter ended August 31, 2005), Amendment (Exhibit 10.3 to Morgan Stanley’s Quarterly Report on Form 10-Q for the quarter ended February 28, 2006), Amendment (Exhibit 10.24 to Morgan Stanley’s Annual Report on Form 10-K for the fiscal year ended November 30, 2006) and Amendment (Exhibit 10.22 to Morgan Stanley’s Annual Report on Form 10-K for the fiscal year ended November 30, 2007)

Exhibit B: Employees’ Equity Accumulation Plan, amended and restated as of November 26, 2007

(Exhibit 10.12 to Morgan Stanley’s Annual Report on Form 10-K for the fiscal year ended November 30, 2007)

Exhibit C: Directors’ Equity Capital Accumulation Plan, as amended and restated as of March 30, 2017

(Exhibit 10.2 to Morgan Stanley’s Current Report on Form 8-K dated May 22, 2017)

Exhibit D: Equity Incentive Compensation Plan, as amended and restated as of March 30, 2017

(Exhibit 10.1 to Morgan Stanley’s Current Report on Form 8-K dated May 22, 2017)

Exhibit E: 2009 Replacement Equity Incentive Compensation Plan for Morgan Stanley Smith Barney Employees

(Exhibit 4.2 to Morgan Stanley’s Registration Statement on Form S-8 (No. 333-159504)).


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:5/4/18424B2,  FWP
For Period end:3/31/1813F-HR,  13F-HR/A,  FWP
1/1/183
5/22/1713F-HR/A,  4,  424B2,  8-K,  DEF 14A,  FWP,  SC 13G
3/30/17424B2
10/18/11424B2
11/30/0710-K,  3/A,  4
11/26/07424B2,  FWP
11/30/0610-K,  424B2,  FWP
2/28/0610-Q,  25,  424B2,  CERTAMX,  FWP
8/31/0510-Q,  424B3,  8-K
11/30/0010-K,  10-K/A,  3,  4
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/22/24  Morgan Stanley                    10-K       12/31/23  224:45M
 2/24/23  Morgan Stanley                    10-K       12/31/22  227:50M
 2/24/22  Morgan Stanley                    10-K       12/31/21  225:51M
 2/26/21  Morgan Stanley                    10-K       12/31/20  225:50M
Top
Filing Submission 0001193125-18-152899   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 4:19:51.1am ET